PubRank

P J Fischinger

Author PubWeight™ 167.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A 1988 8.40
2 A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A 1975 5.91
3 Rapid cell culture assay technic for murine leukaemia viruses. Nature 1971 5.87
4 Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A 1986 5.55
5 Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer 1970 5.48
6 Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 1985 5.42
7 Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A 1986 4.68
8 Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science 1981 4.27
9 Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses 1987 3.67
10 Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol 1990 3.35
11 Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A 1980 3.29
12 Quantitative infectivity assay for HIV-1 and-2. Nature 1988 3.01
13 Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A 1979 2.98
14 Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci U S A 1976 2.86
15 Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol 1974 2.84
16 Isolation of RD-114-like oncornavirus from a cat cell line. J Virol 1973 2.61
17 Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol 1976 2.39
18 Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol 1987 2.28
19 Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A 1971 2.26
20 Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A 1987 2.25
21 Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. J Natl Cancer Inst 1969 1.96
22 Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol 1988 1.95
23 Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology 1976 1.73
24 Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions. Science 1968 1.73
25 Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus. J Virol 1977 1.65
26 Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology 1972 1.59
27 Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell 1977 1.56
28 Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A 1974 1.54
29 Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J Virol 1987 1.49
30 Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. Virology 1978 1.42
31 Isolation of human amnion cells transformed by rescuable murine sarcoma virus. Nat New Biol 1973 1.41
32 A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A 1975 1.37
33 Oncogenic and immunogenic potential of cloned HIX virus in mice and cats. Med Microbiol Immunol 1977 1.37
34 Rescue of murine sarcoma virus from a sarcoma-positive leukemia-negative cell line: requirement for replicating leukemia virus. J Virol 1971 1.32
35 Quantitative interactions of feline leukaemia virus and its pseudotype of murine sarcoma virus in cat cells: requirement for DNA synthesis. J Gen Virol 1971 1.29
36 Revertants of mouse cells transformed by murine sarcoma virus. 3. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus. Virology 1974 1.28
37 Molecular relatedness of mammalian RNA tumor viruses as determined by DNA hybridization. Science 1973 1.28
38 Purification of 120,000 dalton envelope glycoprotein from culture fluids of human immunodeficiency virus (HIV)-infected H9 cells. AIDS Res Hum Retroviruses 1987 1.26
39 Elimination of the sarcoma genome from murine sarcoma virus transformed cat cells. Science 1976 1.26
40 Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology 1972 1.25
41 Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda. Cold Spring Harb Symp Quant Biol 1980 1.24
42 Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated. Virology 1976 1.19
43 Reversion of murine sarcoma virus transformed mouse cells: variants without a rescuable sarcoma virus. Science 1972 1.18
44 Productive infection and morphologic alteration of human cells by a modified sarcoma virus. J Natl Cancer Inst 1970 1.17
45 Efficient release of murine xenotropic oncornavirus after murine leukemia virus infection of mouse cells. Virology 1975 1.16
46 Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Proc Natl Acad Sci U S A 1987 1.14
47 Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks. Science 1978 1.14
48 Radiation leukemia virus: quantitative tissue culture assay. Science 1969 1.13
49 Use of an established cat cell line for investigation and quantitation of feline oncornaviruses. J Natl Cancer Inst 1972 1.13
50 Viral infection across species barriers: reversible alteration of murine sarcoma virus for growth in cat cells. Science 1969 1.13
51 Characterization of RNA from noninfectious virions produced by sarcoma positive-leukemia negative transformed 3T3 cells. Proc Natl Acad Sci U S A 1973 1.11
52 Properties of mouse leukemia viruses. II. Isolation of viral components. Virology 1972 1.10
53 Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology 1972 1.06
54 Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculation. Arch Virol 1987 1.05
55 Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III). Cancer Res 1985 1.01
56 Identification of virus found in mouse lymphomas induced by HIX murine oncornavirus. J Virol 1978 0.98
57 Tissue culture assay of helper activity of murine leukemia virus for murine sarcoma virus. J Natl Cancer Inst 1968 0.98
58 Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus. J Gen Virol 1988 0.98
59 Further characterization of the oncornavirus inactivating factor in normal mouse serum. Virology 1979 0.98
60 Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71. Virology 1981 0.98
61 Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures. J Natl Cancer Inst 1969 0.96
62 Role of carbohydrate in biological functions of Friend murine leukemia virus gp71. J Virol 1977 0.94
63 Replication of radiation-induced murine leukemia virus in normal and transformed mouse cells. J Virol 1972 0.93
64 Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF. J Virol 1988 0.93
65 Effect of helper virus on the number of murine sarcoma virus DNA copies in infected mammalian cells. J Virol 1977 0.93
66 Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice. Virology 1976 0.92
67 Two levels of restriction by mouse or cat cells of murine sarcoma virus coated by endogenous xenotropic oncornavirus. J Gen Virol 1975 0.92
68 Oncoduction. A unifying hypothesis of viral carcinogenesis. Prog Exp Tumor Res 1974 0.92
69 Effect of infection with Moloney sarcoma and leukemia viruses on nucleic acid synthesis in mouse cell cultures. J Natl Cancer Inst 1970 0.92
70 Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120). Vaccine 1989 0.90
71 Thymotropic envelope gene recombinants of Moloney leukemia virus have highly conserved envelope structures. Virology 1985 0.90
72 Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines. Cancer Res 1982 0.89
73 Role of heated adenovirus 2 in viral interference. Proc Soc Exp Biol Med 1965 0.89
74 Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71. Virology 1979 0.89
75 The inhibition by cytosine arabinoside of the replication of murine leukemia and sarcoma viruses in mouse embryo cultures. Int J Cancer 1969 0.88
76 Toward a vaccine against AIDS: rationale and current progress. Mt Sinai J Med 1986 0.87
77 Lipoprotein-associated oncornavirus-inactivating factor in the genus Mus: effects on murine leukemia viruses of laboratory and exotic mice. Cancer Res 1987 0.87
78 Replication of defective and competent forms of murine sarcoma virus in mouse cell cultures. Virology 1970 0.87
79 Properties of mouse leukemia viruses. XIV. Prevention of spontaneous AKR leukemia by treatment with group-specific antibody against the major virus gp71 glycoprotein. Virology 1977 0.87
80 The development of an AIDS vaccine: progress and promise. Public Health Rep 1988 0.87
81 Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells. Proc Natl Acad Sci U S A 1981 0.86
82 XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells. Virology 1982 0.86
83 Spontaneous lymphomas in SJL/J-(v+) mice: ecotropic and dualtropic virus expression in normal and lymphomatous tissues. J Natl Cancer Inst 1981 0.85
84 Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluordeoxyuridine and colcemid. Virology 1973 0.85
85 HTLV-III antibody in a breeding chimpanzee not experimentally exposed to the virus. Lancet 1986 0.83
86 Ultraviolet inactivation of Moloney leukaemia virus: relative target size required for virus replication and rescue of 'defective' murine sarcoma virus. J Gen Virol 1972 0.82
87 Expression of the defective "S plus L-" type murine sarcoma virus genome in human amnion and lung cells. J Natl Cancer Inst 1974 0.82
88 Microinjection and expression of an infectious proviral clone and subgenomic envelope construct of a human immunodeficiency virus. AIDS Res Hum Retroviruses 1988 0.79
89 Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. J Exp Med 1974 0.78
90 Activating and protective capacities of a purified electrophoretic fraction of murine leukemia virus for murine leukemia virus infectivity. Proc Natl Acad Sci U S A 1972 0.78
91 Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus. Virology 1984 0.78
92 Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein. Haematol Blood Transfus 1987 0.78
93 Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells. Cancer Res 1982 0.78
94 Revertants of mouse cells transformed by murine sarcoma virus: flat variants without a rescuable sarcoma virus from a clone of BALB/3T3 transformed by Kirsten MSV. J Gen Virol 1974 0.78
95 Biological, immunological, and molecular properties of revertants of cat cells transformed by murine sarcoma virus. Cancer Res 1981 0.78
96 Induction of a novel transforming virus (MSV-Z) from sarcoma-positive leukemia-negative 3T3FL mouse cells. Virology 1976 0.77
97 Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice. Virology 1976 0.77
98 Isolation of two novel envelope recombinant leukemogenic viruses from Moloney leukemia virus stocks. Int J Cancer 1981 0.77
99 Rapid assessment of relationships among HIV isolates by oligopeptide analyses of external envelope glycoproteins. AIDS Res Hum Retroviruses 1987 0.77
100 Properties of 3T3 cells transformed by murine sarcoma virus in the absence of replicating murine leukemia helper virus. Bibl Haematol 1973 0.77
101 Prospects for treatment of human retrovirus-associated diseases. Cancer Res 1985 0.76
102 Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies. AIDS Res Hum Retroviruses 1988 0.76
103 Pathogenesis and virus content of lymphomas induced by pure ecotropic Graffi murine leukemia virus. Int J Radiat Oncol Biol Phys 1985 0.76
104 Selective host range restriction of goat cells for recombinant murine leukemia virus and feline leukemia virus type A. J Virol 1981 0.75
105 Advanced computing. Science 1984 0.75
106 The role of viral and cellular recombinational events in murine leukemia. Transplant Proc 1984 0.75
107 Establishment of two canine sarcoma cell lines: productive infection with feline leukemia virus. J Natl Cancer Inst 1975 0.75
108 Acquired immune deficiency syndrome: the causative agent and the evolving perspective. Curr Probl Cancer 1985 0.75
109 Persistence of one species of oncovirus in mixed infection after antiserum treatment or transspecies rescue. J Gen Virol 1982 0.75
110 Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis. Virology 1976 0.75
111 Generation of recombinant murine leukemia viruses de novo: an alternative model for leukemogenesis. Haematol Blood Transfus 1983 0.75
112 Human amnion and lung tissue culture systems for possible detection and study of human RNA tumor viruses. Bibl Haematol 1975 0.75
113 Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and cats. Med Microbiol Immunol 1977 0.75
114 Mammalian C-type oncorna viruses. Relationships between structural virus and cell surface antigens and their possible significance in immunological defense mechanisms. Bibl Haematol 1975 0.75
115 Governance of science at the National Cancer Institute: perceptions and opportunities in oncogene research. Cancer Res 1984 0.75
116 Properties of Moloney sarcoma virus-specific p60 and its detection in transformed cells. Bibl Haematol 1975 0.75
117 Control of reversion of Moloney virus sarcoma virus transformed cells. Bibl Haematol 1975 0.75
118 Rapid screening assay for revertants derived from MSV-transformed cells. Nature 1973 0.75
119 Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus. J Natl Cancer Inst 1978 0.75
120 Infection and transformation of dog cells with a modified sarcoma virus. J Natl Cancer Inst 1970 0.75
121 Rapid screening assay for revertants of murine sarcoma virus-transformed cells. Methods Cell Biol 1976 0.75
122 Physical alterations of a murine leukemia virus complex in mammalian cell cultures. Bibl Haematol 1970 0.75
123 Generation of thymotropic envelope gene recombinant virus and induction of lymphoma by ecotropic Moloney murine leukemia virus. Virology 1985 0.75